ACST updated about its plans to acquire Grace Therapeutics and the ongoing strategic process for CaPre.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
